Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jiaqi Pu, Qun Yi, Yuanming Luo, Hailong Wei, Huiqing Ge, Huiguo Liu, Xianhua Li, Jianchu Zhang, Pinhua Pan, Hui Zhou, Chen Zhou, Mengqiu Yi, Lina Cheng, Liang Liu, Jiarui Zhang, Lige Peng, Adila Aili, Yu Liu & Haixia Zhou. (2023) Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 169-179.
Read now
Read now
Yao-Kuang Wu, Wen-Lin Su, Mei-Chen Yang, Sin-Yi Chen, Chih-Wei Wu & Chou-Chin Lan. (2021) Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2475-2485.
Read now
Read now
Junnan Peng, Qian Yu, Shulei Fan, Xingru Chen, Rui Tang, Daoxin Wang & Di Qi. (2021) High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 795-806.
Read now
Read now
Articles from other publishers (8)
Yaolin Li, Huiqin Wang, Lixiang Jiang, Long Chen, Kai Zhao & Xiayahu Li. (2023) A bibliometric analysis of chronic obstructive pulmonary disease and COVID-19. Medicine 102:10, pages e33240.
Crossref
Crossref
Ulrika Margareta Wallgren, Hans Järnbert-Pettersson, Jan Sjölin & Lisa Kurland. (2022) Association between variables measured in the ambulance and in-hospital mortality among adult patients with and without infection: a prospective cohort study. BMC Emergency Medicine 22:1.
Crossref
Crossref
Ourania S. Kotsiou, Ioannis Pantazopoulos, Georgios Mavrovounis, Konstantinos Marsitopoulos, Konstantinos Tourlakopoulos, Paraskevi Kirgou, Zoe Daniil & Konstantinos I. Gourgoulianis. (2022) Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma. Journal of Personalized Medicine 12:11, pages 1776.
Crossref
Crossref
Ria M. Holstein, Santeri Seppälä, Johanna Kaartinen, Mari Hongisto, Harri Hyppölä & Maaret Castrén. (2022) Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients. Journal of Clinical Medicine 11:12, pages 3283.
Crossref
Crossref
Yunhuan Liu, Guanhua Ma, Yan Mou, Xuanqi Liu, Wenjia Qiu, Yang Zheng, Huili Zhu & Haiyan Ge. (2022) The Combined Value of Type2 Inflammatory Markers in Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 11:10, pages 2791.
Crossref
Crossref
Ria M Holstein, Marja T Mäkinen, Maaret K Castrén & Johanna M Kaartinen. (2022) Utilization of Prognostic Biomarker Soluble Urokinase Plasminogen Activator Receptor in the Emergency Department: A Tool for Safe and More Efficient Decision-making. Biomarker Insights 17, pages 117727192210817.
Crossref
Crossref
Seppälä Santeri, Andersen Andreas Peter, Nyyssönen Kristiina, Eugen-Olsen Jesper & Hyppölä Harri. (2021) suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department. BMC Emergency Medicine 21:1.
Crossref
Crossref
Izzet Altintas, Jesper Eugen-Olsen, Santeri Seppälä, Jens Tingleff, Marius Ahm Stauning, Nora Olsen El Caidi, Sanaá Elmajdoubi, Hejdi Gamst-Jensen, Mette B Lindstrøm, Line Jee Hartmann Rasmussen, Klaus Tjelle Kristiansen, Christian Rasmussen, Jan O Nehlin, Thomas Kallemose, Harri Hyppölä & Ove Andersen. (2021) suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19. Biomarker Insights 16, pages 117727192110346.
Crossref
Crossref